| Comment Record |
|
Commentor |
Ms. Judy Lance |
Date/Time |
2002-11-05 10:38:40 |
|
Organization |
Glynn County Health Department |
|
Category |
Health Professional |
| Comments for FDA General |
| Questions |
|
1. General Comments
|
While a safer smallpox vaccine would be appreciated, there is not one at this time. I feel it is worth the risk to conduct this trial because: 1) we do not know where existing supplies of the smallpox virus in the world are (high risk) and the death rate for smallpox in children is high, especially in children 1 y/o or younger. US citizens who are over the age of 30 y/o have already received at least one dose of vaccine and may have some residual immunity, but our children have none.
|
|